A Case of Thyroid Crisis With Worsening Jaundice Despite Improvements in Heart Failure

Hiroshi Yamaguchi, Ayaka Takahashi, Atsuhisa Shirakami, Norihito Kageyama, Ken-ichi Kitazoe, Hiroyuki Fujinaga


We herein present a case of a 33-year-old woman who was referred to our hospital for dyspnea on effort 2 months before her admission. Although diffuse enlargement of the thyroid gland occurred at the age of 23, she did not undergo detailed medical examinations. She was diagnosed with hyperthyroidism due to Graves’ disease, and the administration of methimazole was initiated at a dosage of 30 mg/day. She had congestive heart failure, rapid atrial fibrillation, and disseminated intravascular coagulation on admission. Thyroid crisis was diagnosed based on the diagnostic criteria of the Japan Endocrine Society (second edition). Although cardiac function and heart failure symptoms improved, her total bilirubin level continued to increase and peaked at 28.8 mg/dL. Her bilirubin level was reduced by anti-thyroid drugs and eventually normalized in parallel with improvements in thyroid function. Jaundice may have occurred as a secondary consequence of cholestasis due to hyperthyroidism because other causes such as drug-induced or autoimmune liver dysfunction were ruled out. We herein report a rare case of thyroid crisis with worsening jaundice despite improvements in heart failure. This case demonstrated that obtaining a detailed medical history and a careful examination of the clinical course were useful for reaching the differential diagnosis of severe jaundice and achieving steady improvements in this serious medical condition.

J Endocrinol Metab. 2016;6(2):59-63
doi: http://dx.doi.org/10.14740/jem345w


Thyroid crisis; Graves’ disease; Jaundice; Atrial fibrillation; Heart failure; Cholestatic hepatic injury

Full Text: HTML PDF
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe



Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board



Company Profile

Editorial Office

Misconduct and Retraction


Company Registration

Contact Us

Abstracting and Indexing



Instructions to Authors


Declaration of Helsinki

Contact Publisher

Submission Checklist


Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy


Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians


Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal


Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.